Precigen logo

Precigen Share Price Today

(NASDAQ: PGEN)

Precigen share price is $1.39 & ₹118.80 as on 18 Apr 2025, 2.30 'hrs' IST

$1.39

0.02

(1.46%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Precigen share price in Dollar and Rupees. Guide to invest in Precigen stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Precigen, along with analyst recommendations, forecasts, and comprehensive financials.

Precigen share price movements

  • Today's Low: $1.34
    Today's High: $1.43

    Day's Volatility :6.64%

  • 52 Weeks Low: $0.65
    52 Weeks High: $2.17

    52 Weeks Volatility :69.99%

Precigen (PGEN) Returns

PeriodPrecigen IncSector (Health Care)Index (Russel 2000)
3 Months
17.8%
-2.8%
0.0%
6 Months
49.91%
-11.0%
0.0%
1 Year
4.51%
-1.9%
0.0%
3 Years
-6.08%
-1.5%
-12.9%

Precigen (PGEN) Key Statistics

in dollars & INR

Previous Close
$1.37
Open
$1.36
Today's High
$1.43
Today's Low
$1.335
Market Capitalization
$408.7M
Today's Volume
$1.1M
52 Week High
$2.17
52 Week Low
$0.6513
Revenue TTM
$3.9M
EBITDA
$-90.2M
Earnings Per Share (EPS)
$-0.47
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-160.8%

How to invest in Precigen Stock (PGEN) from India?

It is very easy for Indian residents to invest directly in Precigen from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Precigen stock in both Indian Rupees (INR) and US Dollars (USD). Search for Precigen or PGEN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Precigen or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Precigen shares which would translate to 0.615 fractional shares of Precigen as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Precigen, in just a few clicks!

Returns in Precigen (PGEN) for Indian investors in Rupees

The Precigen stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Precigen investment value today

Current value as on today

₹1,06,852

Returns

₹6,852

(+6.85%)

Returns from Precigen Stock

₹4,511 (+4.51%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Precigen (PGEN)

-10%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Precigen Stock from India on INDmoney has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Precigen

  • Patients Capital Management LLC

    6.08%

  • Adage Capital Partners Gp LLC

    3.70%

  • BlackRock Inc

    3.53%

  • Vanguard Group Inc

    2.83%

  • Iridian Asset Management LLC

    1.78%

  • Geode Capital Management, LLC

    1.12%

Analyst Recommendation on Precigen

Rating
Trend

Buy

    81%Buy

    9%Hold

    9%Sell

Based on 11 Wall street analysts offering stock ratings for Precigen(by analysts ranked 0 to 5 stars)

Analyst Forecast on Precigen Stock (PGEN)

What analysts predicted

Upside of 337.41%

Target:

$6.08

Current:

$1.39

Insights on Precigen Stock (Ticker Symbol: PGEN)

  • Price Movement

    In the last 3 months, PGEN stock has moved up by 23.4%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 717.0K → 1.19M (in $), with an average increase of 22.3% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -58.79M → -19.72M (in $), with an average increase of 83.4% per quarter
  • PGEN vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 73.1%
  • PGEN vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 44.9%
  • Price to Sales

    ForPGEN every $1 of sales, investors are willing to pay $92.7, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

Precigen Technicals Summary

Sell

Neutral

Buy

Precigen is currently in a neutral trading position according to technical analysis indicators.

Precigen (PGEN) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Precigen Inc logo
-23.89%
49.91%
4.51%
-6.08%
-60.29%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Precigen

Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases. It operates through two segments, Biopharmaceuticals and Exemplar. The company offers therapeutic platforms consisting of AdenoVerse platform, which utilizes a library of proprietary adenovectors for gene delivery of therapeutic effectors, immunomodulators, and vaccine antigen; and UltraCAR-T to provide chimeric antigen receptor T cell therapies for cancer patients. It also develops programs based on the UltraCAR-T platform, including PRGN-3005 in Phase 1b clinical trial to treat advanced ovarian, fallopian tube, or primary peritoneal cancer; PRGN-3006 in Phase 1b trial for patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndromes; and PRGN-3007 in Phase 1/1b trial for the treatment of advanced receptor tyrosine kinase-like orphan receptor 1-positive, hematologic, and solid tumors. In addition, the company is developing programs based on the AdenoVerse immunotherapy platform comprising PRGN-2009 in Phase 2 trial for patients with HPV+ solid tumors; PRGN-2012 in Phase ½ trial to treat recurrent respiratory papillomatosis; and AG019, which is in Phase 1b/2a trial, to treat type 1 diabetes mellitus. Further, it provides UltraPorator, a proprietary electroporation device; and develops research models and services for healthcare research applications. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in February 2020. Precigen, Inc. was founded in 1998 and is headquartered in Germantown, Maryland.
Organization
Precigen
Employees
143
CEO
Dr. Helen Sabzevari MPH, Ph.D.
Industry
Health Technology

Management People of Precigen

NameTitle
Mr. Randal J. Kirk J.D.
Executive Chairman
Dr. Helen Sabzevari MPH, Ph.D.
President, CEO & Director
Mr. Harry Thomasian Jr.
Chief Financial Officer
Mr. Rutul R. Shah
Chief Operating Officer
Mr. Donald P. Lehr J.D., Ph.D.
Chief Legal Officer & Corporate Secretary
Mr. Steven Harasym
VP & Head of Investor Relations
Mr. Rob Russell
VP & Head of Human Resources
Dr. Douglas E. Brough Ph.D.
Senior VP & Head of Research
Dr. Bryan T. Butman Ph.D.
Senior VP & Head of CMC
Dr. Amy R. Lankford Ph.D.
Senior VP & Head of Clinical Operations and Regulatory Affairs

Important FAQs about investing in PGEN Stock from India :

What is Precigen share price today?

Precigen share price today stands at $1.39, Open: $1.36 ; Previous Close: $1.37 ; High: $1.43 ; Low: $1.34 ; 52 Week High: $2.17 ; 52 Week Low: $0.65.

The stock opens at $1.36, after a previous close of $1.37. The stock reached a daily high of $1.43 and a low of $1.34, with a 52-week high of $2.17 and a 52-week low of $0.65.

Can Indians buy Precigen shares?

Yes, Indians can invest in the Precigen (PGEN) from India.

With INDmoney, you can buy Precigen at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Precigen at zero transaction cost.

How can I buy Precigen shares from India?

It is very easy to buy Precigen from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Precigen (PGEN) be purchased?

Yes, you can buy fractional shares of Precigen with INDmoney app.

What are the documents required to start investing in Precigen stocks?

To start investing in Precigen, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Precigen Stock (PGEN)?

Today’s highest price of Precigen (PGEN) is $1.43.

Today’s lowest price of Precigen (PGEN) is $1.34.

What is today's market capitalisation of Precigen?

Today's market capitalisation of Precigen PGEN is 408.7M

What is the 52 Week High and Low Range of Precigen Stock (PGEN)?

  • 52 Week High

    $2.17

  • 52 Week Low

    $0.65

What are the historical returns of Precigen (PGEN)?

  • 1 Month Returns

    -23.89%

  • 3 Months Returns

    49.91%

  • 1 Year Returns

    4.51%

  • 5 Years Returns

    -60.29%

Who is the Chief Executive Officer (CEO) of Precigen ?

Dr. Helen Sabzevari MPH, Ph.D. is the current Chief Executive Officer (CEO) of Precigen.